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Abstract
Background: Solid pancreatic tumors such as pancreatic ductal adenocarcinoma (PDAC), solid pseudopapillary
tumor (SPT), and pancreatic endocrine tumor (PET) may occasionally manifest as cystic lesions. In this study, we
have put together our accumulated experience with cystic manifestations of various solid tumors of the pancreas.
Methods: From 2000 to 2006, 376 patients with pancreatic solid tumor resections were reviewed. Ten (2.66%) of
these tumors appeared on radiological imaging studies as cystic lesions. We performed a retrospective review of
medical records and pathologic findings of these 10 cases.
Results: Of the ten cases in which solid tumors of the pancreas manifested as cystic lesions, six were PDAC with
cystic degeneration, two were SPT undergone complete cystic change, one was cystic PET, and one was a cystic
schwannoma. The mean tumor size of the cystic portion in PDAC was 7.3 cm, and three patients were diagnosed
as ‘pseudocyst’ with or without cancer. Two SPT were found incidentally in young women and were diagnosed as
other cystic neoplasms. One cystic endocrine tumor was preoperatively suspected as intraductal papillary mucinous
neoplasm or mucinous cystic neoplasm.
Conclusions: Cystic changes of pancreas solid tumors are extremely rare. However, the possibility of cystic
manifestation of pancreas solid tumors should be kept in mind.
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Background
Pancreatic cystic tumors are frequently and increasingly
diagnosed due to improvement of imaging quality and
increased frequency of imaging diagnosis. Interestingly,
solid pancreas neoplasma may undergo degeneration or
change in its structure to appear as cystic tumors, mask-
ing its originality as a solid pancreas neoplasm. Clini-
cally, most of pancreatic cystic tumors are benign, but
cystic degeneration of solid tumors are frequently malig-
nant, especially pancreatic ductal adenocarcinoma
(PDAC). As the significance of the cystic lesions
emerged, cystic forms of otherwise typically solid tumors
were also better characterized [1]. Solid-pseudopapillary
tumor (SPT) and PDAC may exhibit large cystic degen-
erations with hemorrhagic and necrotic debris on rare
occasions [2]. Such cystic tumors are often mistaken for
pseudocyst of the pancreas by imaging studies and
macroscopic examinations [3]. Other forms of pancrea-
tic cystic lesions, for example cystic pancreatic endo-
crine tumor (PET), are extremely uncommon. We
report solid pancreatic tumors exhibited as cystic
tumors in imaging or gross appearances before patholo-
gic examination in a single referred institute.
Methods
From 2000 to 2006, 376 patients at our center who
underwent pancreas solid tumor resection (PDAC, PET,
etc.) and patients who were diagnosed with SPT were
reviewed retrospectively. Ten (2.66%) of these 376
tumors were diagnosed on radiological imaging as cystic
lesions. Any tumors with the impression of solid or
m i x e dc y s t i cc o m p o n e n to ni m a g ef i n d i n g sw e r en o t
included in this study. Medical records and pathologic
findings were reviewed retrospectively. Solid pancreatic
tumors include PDAC, PET, gastrointestinal stromal
tumor (GIST), metastatic tumor, and schwannoma. We
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neoplasm (SCN), mucinous cystic neoplasm (MCN),
intraductal papillary mucinous neoplasm (IPMN) in this
study. SPT is well known as a tumor with cystic mani-
festation and can contain mixed solid and cystic por-
tions. We found six SPT cases displaying cystic changes,
and hence were included in this study. But we excluded
four SPT cases containing calcification in the wall or
any small solid components found on radiologic or
pathologic report.
Results
Cases of six PDAC with cystic degenerations, two cystic
changes of the SPT, one cystic PET, and one cystic
schwannoma were included in this study.
PDAC
The mean age of patients with PDAC cystic changes
were 62.7 years (38-78 years). All six patients had
abdominal or flank pain and one showed jaundice. CT
images were reviewed but endoscopic ultrasonogram
(EUS) or Positron Emission Tomogaraphy images were
not performed. Of the six cases, five showed elevated
carbohydrate antigen (CA 19-9) levels (59-2077 IU/ml)
where as one showed normal CA 19-9 level. Initially
based on clinical manifestation and imaging study find-
ings, three were diagnosed as ‘pseudocyst’ with or with-
out PDAC and three lesions were suspected malignant
IPMN or other form of cystic neoplasms. Two patients
with suspected ‘pseudocyst with cancer’ had history of
chronic pancreatitis. However, one other patient with
suspected ‘pseudocyst’ in imaging findings did not have
history of pancreatitis. This patient showed the largest
cyst and was referred to our center after external drai-
nage of the cyst. CA19-9 level of the cystic fluid was
24000 IU/ml but no malignant cells were found. How-
ever, we decided to proceed with operation of the pan-
creatic cyst due to sustained pain after external drainage
and also because we concluded that the possibility of
hidden malignancy could not be completely ruled out.
We did not perform routine cystic fluid aspiration or
tumor marker tests.
Of the PDAC tumors, the mean size of tumors was
7.3 cm (3.0-11.0 cm). Two patients with cystic PDAC
showed multiple lesions in the pancreas. We performed
two pancreaticoduodenectomies, three distal pancreatec-
tomies, and one total pancreatectomy. All tumors except
one which was suspicious of IPMN had grossly detect-
able invasion to adjacent organ such as the colon, sto-
mach, and kidney. Hence four patients underwent
transverse colectomy for severe adherence and com-
bined gastrectomy, and one patient underwent adrena-
lectomy. Pathologic findings revealed invasion to
adjacent organs in three lesions, showing cancer cell
invasion of the cystic wall (Figure 1). The clinical fea-
tures of all six patients with PDAC cystic degeneration
are summarized in Table 1.
SPT
Two cystic SPTs were detected incidentally in two
young women by screening. Based on imaging findings,
diagnosis of MCN were made for both patients and in
one lesion, dermoid cyst or hemorhhagic cyst was sus-
pected. Although focal calcifications were found in cys-
tic walls of both, SPT was not suspected. Each tumor
was located in the pancreas head and tail portion, and
they underwent Pylorus preserving pancreaticoduode-
nectomy (PPPD) and distal pancreatectomy (DP) respec-
tively. Both tumors contained muddy chocolate
materials which is suspicious of hemorrhagic debris
(Figure 2).
Immunohistochemistry test was performed on the
cells of the cyst walls and the results showed positive
findings for CD10 but negative findings for chromogra-
nin and synaptophysin based upon which the pathologi-
cal diagnosis of SPT was made, with one revealing
benign features whereas the other showed low grade
malignancy. Clinical features of the SPT tumors are
depicted in Table 2.
Cystic PET
A cystic mass on the pancreas head suspected of MCM
or IPMN was found in a computed tomography (CT)
performed on a 53 year old female patient which was
done for the purpose of evaluating uncontrolled DM
and weight loss. (Figure 2a) She underwent PPPD and
t h em a s sf o u n dw a sm e a s u r e dt ob e3 . 5×3 . 3c m .T h i s
tumor displayed CD10 negative, chromogranin positive,
synaptophysin positive, and vimentin weak positive find-
ings on immunohistochemistry which led to a pathologi-
cal diagnosis of well differentiated benign cystic PET.
Cystic schwannoma
CT findings of a 77 year old female patient with epigas-
tric pain revealed a cystic tumor of the pancreas head
which contained a papillary protruding solid mass
within the cyst and a diagnosis of either SPT or PET
was made based upon these findings. PPPD was per-
formed and the tumor was found to be filled with ser-
ous fluid, which was stained positive for S100 protein.
Thus, the tumor was confirmed as a cystic schwannoma.
The clinical features of the ten patients reviewed in
this study are summarized in Table 3.
Discussion
Owing to recent improvement in abdominal imaging
and invasive diagnostic techniques, an increasing num-
ber of pancreas cystic lesions are identified in patients
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Page 2 of 6Figure 1 PDAC with cystic degeneration. (a) CT shows huge cystic pancreas mass in tail portion. (b,c) Macroscopic appearance of the tumor
showing big degenerative cyst which wall is severly thickened. (d,e) Microscopic finding of tumor wall contains cancer cell with poorly
differentiation.
Table 1 Clinical aspects in patient with the pancreatic ductal adenocarcinoma cystic degeneration.
Age (mean,range) (yr) 62.7
Gender (male/female) 2/4
Chief complaint Abdominal pain 5
jaundice 1
CA 19-9 < 37 IU/ml 2
≥ 37 IU/ml 4 (range: 59~2077)
Radiologic diagnosis pseudocyst 3
Cystic neoplasm 3
Location head 2
body and tail 4
Operation pancreaticoduodenectomy 2 (add colectomy 1)
distal pancreatectomy 3 (add colectomy 2)
total pancreatectomy 1 (add gastrectomy and colectomy 1)
Size (mean,range) (cm) 7.3 (3.0 ~ 11.0)
(n = 6)
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well-known pancreas cystic lesions, the differential diag-
nosis of pancreatic cysts also includes cystic changes in
otherwise typically solid tumors of this organ [4]. It is
important to recognize this group, because unlike well-
known pancreas cystic lesions, these are often low grade
malignancies as in the case of SPT or true carcinomas
as in the case of cystic changes in ductal
adenocarcinoma [1]. Cystic feature of solid tumor of
pancreas may result due to necrosis, hemorrhage and
degeneration of tumor cells. Adsay [1] described these
cystic categories in detail.
PDAC with cystic changes have been reported in some
cases [3,5-7]. The largest single institute series of cystic
PDAC was reported in Germany, in which thirty (7.2%)
of 418 cystic tumors of the pancreas were PDAC
Figure 2 Solid pseudopapillary tumor with cystic degeneration. (a) CT shows cystic mass in pancreas head portion. (b-d) Gross appearance
with cyst contains chocolate like materials suggestive with necrotic debrids.
Table 2 Two cases of the solid pseudopapillary tumor with cystic degeneration.
Case 1 (F/34) Case 2 (F/37)
Chief complaint incidental incidental
Lab normal normal
Radiologic diagnosis Dermoid cyst, hemorrhagic cyst, MCN MCN
Operation Distal pancreatectomy PPPD
Pathology benign Cystic degeneration with necrosis, low grade malignancy
Size 9 × 8 cm 8 × 7 cm




MCN: mucinous cystic neoplasm
PPPD: pylorus preserving pancreaticoduodenectomy
CD: cluster of differentiation
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misdiagnosed as pseudocysts based upon imaging stu-
dies before operation. Half of our cases of PDAC with
c y s t i cc h a n g ew e r eo r i g i n a l l ydiagnosed as pseudocysts
with or without cancer before operation. Cystic epithe-
lial cell linings were absent in our cases. German cases
of cystic PDAC showed same staining patterns as the
PDAC [8]. Central necrosis may result in a unilocular
c y s ts u r r o u n d e db yar i mo fv i a b l em a l i g n a n tt i s s u e[ 9 ] .
Pseudocysts in patients with no history of chronic pan-
creatitis should be closely evaluated for differential diag-
nosis of malignancy [3,10,11]. In cases without chronic
pancreatitis, it is possible for pseudocysts accompanying
PDAC to develop due to obstruction of the pancreatic
duct by the tumor [10]. Proper sampling of pseudocysts
is essential and these samples should consist of cyst
walls obtained during open procedures or cyst contents
obtained during minimal access drainage procedures [8].
Kosmahl et al [9] suggested that the discrepancy
between findings of his series in which PDAC with cys-
tic features are frequent and other studies in which
these findings are close to nonexistent may be explained
by the assumption that cystic features in PDAC have
not attracted much attention and have, therefore, prob-
ably been neglected. During a period of six years, our
cases showed a frequency of 1.6% of PDAC with cystic
features. Probably cystic PDAC are more occupied in
cystic pancreas tumor due to large number of observa-
tional small size pancreatic tumors waiting surgical
option in clinical fields. In fact, Kosmahl [9] classified
cystic PDAC as neoplastic epithelial type of cystic pan-
creas neoplasm and lesion in 2004. In Korea, one patient
with PDAC coexisting with pancreatitis and pseudocyst
was reported [12].
In our series, cystic PDAC showed aggressive beha-
vior in CT findings which was checked before opera-
tion. Cyst wall abutted adjacent organs such as the
transeverse colon, stomach,a n dk i d n e y .F o u rp a t i e n t s
underwent combined organ resection. If the pancreas
cystic mass shows aggressive shape on imaging stu-
dies, malignancies such as PDAC should be suspected.
We made operation decisions based upon CT as the
only imaging modality. If we performed Positron
Emission Tomogaraphy (PET) in these cases, malig-
nancy would have been easily suspected and these
cases would have been prepared for more adequate
therapy. Elevated CA 19-9 may also be another clue of
malignancy, especially when pseudocyst is suspected
on image findings.
SPT can show degeneration with cystic features. They
usually start as solid tumors and undergo massive
degeneration giving rise to cystic appearances on radi-
ological imaging [13]. It is now known that the cavities
that are formed in SPTs are not ‘true’ cysts (there is no
epithelial lining) but rather represent a necrotic/degen-
erative process in which the cystic areas consist of
blood, necrotic debris and foamy macrophages [1]. In
our two cases, MCN was suspected preoperatively. SPT
with cystic change is very rare and no single center
report have existed. Recently, CD10 expression and
APC/ß-catenin pathway and cyclin-D1 alterations were
f o u n dt ob ea l m o s tu n i f o r m l yp r e s e n t( >9 0 % )i nS P T s .
This interesting finding is very helpful diagnostically,
and may prove to be important in unraveling the
Table 3 Summary of pancreas solid neoplasms with cystic manifestation.
diagnosis Age/Sex Preoperative Dx operation
1 PDAC 78/M Pseudocyst or PDAC DP/Lt.adrenalectomy/colectomy
2 PDAC 57/M Acute pancreatitis with pseudocyst/PDAC TP/TG/colectomy
3 PDAC 53/F Malignant IPMN PPPD
4 PDAC 79/F Cystic neoplasm PD/colectomy
5 PDAC 71/F MCN DP
6 PDAC 38/F pseudocyst DP/colectomy
7 SPT 34/F Cystic neoplasm DP
8 SPT 37/F MCN PPPD
9 PET 55/F MCN or IPMN PPPD
10 schwannoma 73/F SPT PPPD




IPMN: intraductal papillary mucinous neoplasm
MCN: mucinous cystic neoplasm
SPT: solid pseudopapillary tumor
PPPD: pylorus preserving pancreaticoduodenectomy
PET: pancreatic endocrine tumor
PD: pancreaticoduodenectomy
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Page 5 of 6pathogenesis of this peculiar tumor [1]. We diagnosed
this cystic SPT on basis of CD10 positive findings.
Recently, Bordeianou et al reported the largest series
of cystic PET. PET is no longer considered a pure solid
neoplasm, as it frequently appears with cystic manifesta-
tions. They suggested that cystic PET are more common
than previously thought, and that it should be included
in the differential diagnosis of cystic pancreas neoplasms
[14]. It has been assumed that cystic PET are similar to
solid PET as far as behavior and malignant potential
[15,16]. This assumption derives from the hypothesis
that cystic PET arise as a result of tumor necrosis within
solid PET [17]. Cystic PET are larger and more likely to
be symptomatic than solid PET [14,16]. Our case of
patients with cystic PET had no clinical symptoms and
had a borderline size of 3.5 cm. The tumor contained
serous fluid and pathological diagnosis of cystic PET
was made according to immunohistochemistry findings
which showed chromogranin, synaptophysin positive
findings and CD10 negative findings. Cystic schwan-
noma was very rare compared to previously documented
pancreas cystic neoplasms. Few case reports were pub-
lished [18,19]. Including our cases, all cystic schwanno-
mas stained positive for S100. In our series, consecutive
ten cases of cystic features of solid pancreas neoplasm
were collected retrospectively, and diagnosis was made
depending upon pathologic review. Cystic pancreatic
neoplasm can hide its originality of being a solid neo-
plasm with cystic changes. We always make effort to
make differential diagnosis of pancreatic cystic neo-
plasms using clinical and pathological diagnostic tools
available. The clinically small size of pancreatic cystic
neoplasms can conceal malignant potentials especially of
its solid counterpart.
Conclusions
Cystic formations of the pancreatic solid tumors are
rare. However, the possibility of cystic manifestation
within pancreas solid tumors should be kept in mind.
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